{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:07:45Z","timestamp":1792508865675,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020912","name":"King Faisal University","doi-asserted-by":"publisher","award":["KFU260438"],"award-info":[{"award-number":["KFU260438"]}],"id":[{"id":"10.13039\/501100020912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejphar.2026.178602","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:12:41Z","timestamp":1769213561000},"page":"178602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Reprogramming lysosomal\u2013purinergic crosstalk governs the synergistic attenuation of NLRP3 inflammasome activation by cyclodextrin\u2013P2X7 blockade in diabetic rats"],"prefix":"10.1016","volume":"1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6165-3847","authenticated-orcid":false,"given":"Elsayed A.","family":"Elmorsy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8580-4187","authenticated-orcid":false,"given":"Manal Mohamed","family":"Hatem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4224-0566","authenticated-orcid":false,"given":"Hamad","family":"Alsaykhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz A.","family":"Alsalloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3740-213X","authenticated-orcid":false,"given":"Mostafa M.","family":"Khodeir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2452-1321","authenticated-orcid":false,"given":"Mohammed","family":"Alorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabab S.","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alshaimaa A.","family":"Farrag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7514-1110","authenticated-orcid":false,"given":"Norah Suliman","family":"Alsoqih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Almansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam S.","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1427-032X","authenticated-orcid":false,"given":"Ahmad H.","family":"Alhowail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9521-8368","authenticated-orcid":false,"given":"Hesham Saad","family":"Ata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basem H.","family":"Elesawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Sameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5070-7851","authenticated-orcid":false,"given":"Sameh","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178602_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106601","article-title":"Increased concentrations of P2X7R in oligodendrocyte derived extracellular vesicles of multiple sclerosis patients","volume":"199","author":"Agliardi","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2026.178602_bib2","article-title":"P2X7 receptors from the perspective of NLRP3 inflammasome pathway in depression: potential role of cannabidiol","volume":"41","author":"Akcay","year":"2024","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.ejphar.2026.178602_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1523\/JNEUROSCI.0933-21.2021","article-title":"Repeated administration of 2-Hydroxypropyl-\u03b2-Cyclodextrin (HP\u03b2CD) attenuates the chronic inflammatory response to experimental stroke","volume":"42","author":"Becktel","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178602_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cells14191521","article-title":"Circulating and tissue Galectin-3 in gastrointestinal inflammation: clinical significance and biomarker potential","author":"Brza\u010dki","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.178602_bib5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuropharm.2014.01.045","article-title":"The P2X7 receptor antagonist brilliant blue G attenuates contralateral rotations in a rat model of parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis","volume":"81","author":"Carmo","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.178602_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00167","article-title":"Cathepsin B is required for NLRP3 inflammasome activation in macrophages, through NLRP3 interaction","volume":"8","author":"Chevriaux","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2026.178602_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcell.2020.00167","article-title":"Cathepsin B is required for NLRP3 inflammasome activation in macrophages, through NLRP3 interaction","volume":"8","author":"Chevriaux","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2026.178602_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fncel.2017.00355","article-title":"Cyclodextrins and iatrogenic hearing loss: new drugs with significant risk","volume":"11","author":"Crumling","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178602_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bonr.2022.101608","article-title":"Extracellular ATP and its derivatives provide spatiotemporal guidance for bone adaptation to wide spectrum of physical forces","author":"Dsouza","year":"2022","journal-title":"BoneKEy Rep."},{"key":"10.1016\/j.ejphar.2026.178602_bib10","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.178602_bib11","first-page":"16","article-title":"E1231\/NMN protects against experimental metabolic syndrome: the central role of SIRT1 in modulating AKT\/Nrf2\/NF\u03baB signaling","volume":"ume","author":"Elmorsy","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178602_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122966","article-title":"Modulating the HSP90 control over NF\u03baB\/NLRP3\/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: insights into the role of TAS-116 (Pimitespib)","volume":"354","author":"Elmorsy","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2026.178602_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152599","article-title":"Dietary fat, cholesterol, and cholic acid affect the histopathologic severity of nonalcoholic steatohepatitis in Sprague-Dawley rats","volume":"215","author":"Fukuda","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ejphar.2026.178602_bib14","doi-asserted-by":"crossref","first-page":"e1048","DOI":"10.1002\/ctm2.1048","article-title":"Hepatic interleukin-1 receptor type 1 signalling regulates insulin sensitivity in the early phases of nonalcoholic fatty liver disease","volume":"12","author":"Gehrke","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.178602_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178202","article-title":"Sirtuin 6-driven ASC deacetylation confers hepatoprotection: a promising approach to inflammasome inhibition in experimental NASH","volume":"1006","author":"Hamad","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178602_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115452","article-title":"MDL-800 protects against inflammatory and metabolic dysfunction: role of SIRT6 in the cross-regulation of NF\u03baB, AMPK, and PPAR signaling in rats","volume":"165","author":"Hamad","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2026.178602_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep4.1801","article-title":"Role of cholesterol-associated steatohepatitis in the development of NASH","volume":"6","author":"Horn","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ejphar.2026.178602_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/hep4.1801","article-title":"Role of cholesterol\u2010associated steatohepatitis in the development of NASH","volume":"6","author":"Horn","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ejphar.2026.178602_bib19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep4.1348","article-title":"Cholesterol crystals in hepatocyte lipid droplets are strongly associated with human nonalcoholic steatohepatitis","volume":"3","author":"Ioannou","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ejphar.2026.178602_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1210\/en.2006-0692","article-title":"Interleukin-1\u03b2-Induced insulin resistance in adipocytes through down-regulation of insulin receptor Substrate-1 expression","volume":"148","author":"Jager","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2026.178602_bib21","doi-asserted-by":"crossref","first-page":"15871","DOI":"10.1021\/acs.analchem.4c00355","article-title":"Real-time monitoring of oxygen-consumption rate in mouse liver slices incubated in Organ-on-a-Chip devices","volume":"96","author":"Karsten","year":"2024","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejphar.2026.178602_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11481-024-10101-5","article-title":"New insights on NLRP3 inflammasome: mechanisms of activation, inhibition, and epigenetic regulation","volume":"19","author":"Kodi","year":"2024","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178602_bib23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41419-022-04786-w","article-title":"Targeted P2X7\/NLRP3 signaling pathway against inflammation, apoptosis, and pyroptosis of retinal endothelial cells in diabetic retinopathy","volume":"13","author":"Kong","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2026.178602_bib24","article-title":"SIRT2 deficiency aggravates diet-induced nonalcoholic fatty liver disease through modulating Gut Microbiota and metabolites","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178602_bib25","first-page":"15","article-title":"Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders","volume":"ume","author":"Liu","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178602_bib26","article-title":"Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178602_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12986-016-0074-1","article-title":"High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications","volume":"13","author":"Lozano","year":"2016","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.ejphar.2026.178602_bib28","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/14728222.2023.2258280","article-title":"Galectin-3: therapeutic targeting in liver disease","volume":"27","author":"Mackinnon","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2026.178602_bib29","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.kint.2018.06.031","article-title":"Hydroxypropyl-\u03b2-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis","volume":"94","author":"Mitrofanova","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2026.178602_bib30","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.kint.2018.06.031","article-title":"Hydroxypropyl-\u03b2-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis","volume":"94","author":"Mitrofanova","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2026.178602_bib31","series-title":"Cyclodextrins: Advances in Chemistry, Toxicology, and Multifaceted Applications","author":"Musuc","year":"2024"},{"key":"10.1016\/j.ejphar.2026.178602_bib32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.exphem.2015.11.002","article-title":"Activation of the NLRP3 inflammasome by cellular labile iron","volume":"44","author":"Nakamura","year":"2016","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ejphar.2026.178602_bib33","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fncel.2019.00476","article-title":"P2Y6 and P2X7 receptor antagonism exerts Neuroprotective\/neuroregenerative effects in an animal model of Parkinson's disease","volume":"13","author":"Oliveira-Giacomelli","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178602_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00476","article-title":"P2Y6 and P2X7 receptor antagonism exerts Neuroprotective\/neuroregenerative effects in an animal model of parkinson's disease","volume":"13","author":"Oliveira-Giacomelli","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178602_bib35","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(17)31465-4","article-title":"Intrathecal 2-hydroxypropyl-\u03b2-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1\u20132 trial","volume":"390","author":"Ory","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2026.178602_bib36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41423-025-01284-9","article-title":"Updated insights into the molecular networks for NLRP3 inflammasome activation","volume":"22","author":"Paik","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejphar.2026.178602_bib37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2012.04.028","article-title":"Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes","volume":"685","author":"Qiang","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178602_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajam\u00e4ki","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178602_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1086\/689592","article-title":"Imaging adenosine triphosphate (ATP)","volume":"231","author":"Rajendran","year":"2016","journal-title":"Biol. Bull."},{"key":"10.1016\/j.ejphar.2026.178602_bib40","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/2211-5463.13385","article-title":"Low-level lysosomal membrane permeabilization for limited release and sublethal functions of cathepsin proteases in the cytosol and nucleus","volume":"12","author":"Reinheckel","year":"2022","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.ejphar.2026.178602_bib41","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.2147\/JIR.S315938","article-title":"The supportive role of NSC328382, a P2X7R antagonist, in enhancing the inhibitory effect of CRID3 on NLRP3 inflammasome activation in rats with dextran sodium sulfate-induced colitis","volume":"14","author":"Saber","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ejphar.2026.178602_bib42","article-title":"Recent evaluation about inflammatory mechanisms in nonalcoholic fatty liver disease","volume":"14","author":"Song","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178602_bib43","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3899\/jrheum.110874","article-title":"Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate","volume":"39","author":"Stock","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejphar.2026.178602_bib44","first-page":"191","article-title":"Progress in the correlation between inflammasome NLRP3 and liver fibrosis","volume":"12","author":"Sun","year":"2024","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.ejphar.2026.178602_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102236","article-title":"Monitoring and assessment of lysosomal membrane damage in cultured cells using the high-content imager","volume":"4","author":"Tabata","year":"2023","journal-title":"STAR Protoc."},{"key":"10.1016\/j.ejphar.2026.178602_bib46","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202357574","article-title":"The post-translational regulation of transcription factor EB (TFEB) in health and disease","volume":"24","author":"Takla","year":"2023","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ejphar.2026.178602_bib47","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbrc.2015.02.011","article-title":"Extracellular ATP induces P2X7 receptor activation in mouse kupffer cells, leading to release of IL-1\u03b2, HMGB1, and PGE2, decreased MHC class I expression and necrotic cell death","volume":"458","author":"Toki","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2026.178602_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1220405","article-title":"Pannexin1 channels in the liver: an open enemy","volume":"11","author":"Van Campenhout","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2026.178602_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1220405","article-title":"Pannexin1 channels in the liver: an open enemy","volume":"11","author":"Van Campenhout","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2026.178602_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100780","article-title":"Activation of the NLRP3 inflammasome by CCl(4) exacerbates hepatopathogenic diet-induced experimental NASH","volume":"28","author":"Vargas-Pozada","year":"2023","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.ejphar.2026.178602_bib51","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000200","article-title":"Experimental models of fatty liver diseases: status and appraisal","volume":"7","author":"Wang","year":"2023","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ejphar.2026.178602_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1362996","article-title":"Purinergic enzymes on extracellular vesicles: immune modulation on the go","volume":"15","author":"Winzer","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.178602_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1199519","article-title":"Activation of kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions","volume":"11","author":"Xu","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2026.178602_bib54","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.178602_bib55","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.tcb.2023.01.001","article-title":"Lysosomal quality control: molecular mechanisms and therapeutic implications","volume":"33","author":"Yang","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejphar.2026.178602_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad6100","article-title":"Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming","volume":"8","author":"Zimmer","year":"2016","journal-title":"Sci. Transl. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926000841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926000841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:47:19Z","timestamp":1773985639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926000841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"alternative-id":["S0014299926000841"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178602","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprogramming lysosomal\u2013purinergic crosstalk governs the synergistic attenuation of NLRP3 inflammasome activation by cyclodextrin\u2013P2X7 blockade in diabetic rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178602"}}